Results 121 to 130 of about 113,997,697 (174)

Influenza A(H3N2) Subclade K: Epidemiology, Molecular Evolution and Vaccine Effectiveness in Europe. [PDF]

Pathogens
Scarvaglieri I, De Francesco MA, Alberti M, Cesanelli F, Salvi M, Tiecco G, Castelli F, Quiros-Roldan E.   +7 more
europepmc   +1 more source

Is the emerging influenza A(H3N2) K subclade a specific threat for older adults? [PDF]

Geroscience
Quarleri J, Delpino MV.
europepmc   +1 more source

Molecular Surveillance and Genomic Characterization of Influenza A(H3N2) Viruses From a Secondary-Care Surveillance Site in Pakistan During the 2025-2026 Winter Season. [PDF]

J Med Virol
Javed A, Hayat J, Haider SA, Jamal Z, Hakim R, Ali Q, Bullo MMH, Tahir M, Salman M, Javed Y, Waheed Y, Umair M.   +11 more
europepmc   +1 more source

First detection and transatlantic introduction of Influenza A(H3N2) subclade K (J.2.4.1) into Ecuador: insights from genomic sentinel surveillance. [PDF]

Front Public Health
Bruno A, de Mora D, Olmedo M, Garcés J, Portugal D, Pardo L, Garcia-Bereguiain MA.   +6 more
europepmc   +1 more source

Emergence of influenza A(H3N2) subclade K in northeast Ohio in autumn 2025. [PDF]

J Clin Microbiol
Xu X, Hull W, Plunkett D, Tu ZJ, Ross TM, Rhoads DD, Wang H.   +6 more
europepmc   +1 more source

Influenza A(H3N2) subclade K (J.2.4.1): epidemiology in Asia, clinical context, and the "superflu" framing. [PDF]

New Microbes New Infect
Hariyanto TI.
europepmc   +1 more source

A CNN-Based Model of Cross-Immunity to Influenza A(H3N2) Virus: Testing Under "Real-World" Conditions. [PDF]

Viruses
Asatryan MN, Agasaryan VG, Timofeev BI, Shmyr IS, Shcherbinin DN, Gerasimuk ER, Timofeeva TA, Ershov IF, Semenenko TA, Logunov DY, Gintsburg AL.   +10 more
europepmc   +1 more source

Pre-pandemic contraction, phase-specific rate variation, and site-specific antigenic adaptation shape influenza A(H3N2) evolutionary dynamics in Hubei, China. [PDF]

J Virol
Peng M, Liu L, Li X, Yu X, Yin Q, Zhang X, Han S, Fang B.   +7 more
europepmc   +1 more source

Vaccine-Elicited Antibody Responses to Influenza A(H3N2) Subclade K.

JAMA
Wang L, Nangle SJ, Waller-Pulido A, McMahan K, Pereira J, Chaudhari J, Barrett LO, Bhowmik R, Farrugia K, Ramsamooj R, Sordillo EM, Simon V, van Bakel H, Mostafa H, Pekosz A, Collier AY, Barouch DH.   +16 more
europepmc   +1 more source

Vaccine Effectiveness Estimates Against Influenza A(H3N2)-Associated Hospitalized Severe Acute Respiratory Infections in Beijing, China, 2025/26 Influenza Season. [PDF]

Vaccines (Basel)
Ma C, Zhang J, Ma J, Duan W, Wang Y, Hu X, Li J, Zhang L, Di Y, Yan S, Yang P, Wang Q, Shen Y, Zhang D.   +13 more
europepmc   +1 more source